EPISODE · Sep 4, 2025 · 9 MIN
Stacy Blain is the Founder and CEO of Concarlo Therapeutics, which is the first company to target CDK4/6-driven cell proliferation and CDK2-driven resistance
from Biotech CEO Sisterhood · host BiotechTV
She describes the unmet need for patients who no longer respond to the large CDK4/6 class of medicines, and the decades of work she has put into solving the problem of adding CDK2 inhibition into the equation.
NOW PLAYING
Stacy Blain is the Founder and CEO of Concarlo Therapeutics, which is the first company to target CDK4/6-driven cell proliferation and CDK2-driven resistance
No transcript for this episode yet
Similar Episodes
May 27, 2026 ·1m
May 25, 2026 ·1m
May 25, 2026 ·39m
May 22, 2026 ·1m
May 21, 2026 ·51m
May 17, 2026 ·37m